Search research articles
Contact Us
Filters
Showing results (1-10 of 114) with videos related to
Page
of 12
Sort By:
JACC. Basic to Translational Science
|
August 1, 2018
Effects of Apolipoprotein A-I/High-Density Lipoprotein Cholesterol on Atherosclerotic Vascular Disease: Critical Impact of Atherosclerosis Disease Stage and Disease Milieu?
Arash Haghikia, Ulf Landmesser
Antioxidants & Redox Signaling
|
August 19, 2017
Lipoproteins and Cardiovascular Redox Signaling: Role in Atherosclerosis and Coronary Disease
Arash Haghikia, Ulf Landmesser
Cardiology Clinics
|
April 4, 2018
High-Density Lipoproteins: Effects on Vascular Function and Role in the Immune Response
Arash Haghikia, Ulf Landmesser
European Heart Journal
|
March 11, 2016
Emerging role of the gut microbiome for cardiovascular disease
Arash Haghikia, Ulf Landmesser
Trends in Cardiovascular Medicine
|
September 17, 2018
Editorial commentary: Peripartum cardiomyopathy: Long-term implications of treatment and management
Arash Haghikia, Denise Hilfiker-Kleiner
Cardiovascular Research
|
February 14, 2009
MiRNA-21: a key to controlling the cardiac fibroblast compartment?
Arash Haghikia, Denise Hilfiker-Kleiner
Heart Failure Reviews
|
April 22, 2010
STAT3 and cardiac remodeling
Arash Haghikia, Britta Stapel, Melanie Hoch, et al.
JAK-STAT
|
September 24, 2013
STAT3 regulation of and by microRNAs in development and disease
Arash Haghikia, Melanie Hoch, Britta Stapel, et al.
European Heart Journal
|
February 1, 2015
Peripartum cardiomyopathy: current management and future perspectives
Denise Hilfiker-Kleiner, Arash Haghikia, Justus Nonhoff, et al.
Frontiers in Cardiovascular Medicine
|
January 28, 2022
Immune Mechanisms of Plaque Instability
Teresa Gerhardt, Arash Haghikia, Philip Stapmanns, et al.
Page
of 12
Search research articles
Search
Showing results (1-10 of 114) with videos related to
Sort By:
Page
of 12
JACC. Basic to Translational Science
|
August 1, 2018
Effects of Apolipoprotein A-I/High-Density Lipoprotein Cholesterol on Atherosclerotic Vascular Disease: Critical Impact of Atherosclerosis Disease Stage and Disease Milieu?
Arash Haghikia, Ulf Landmesser
Antioxidants & Redox Signaling
|
August 19, 2017
Lipoproteins and Cardiovascular Redox Signaling: Role in Atherosclerosis and Coronary Disease
Arash Haghikia, Ulf Landmesser
Cardiology Clinics
|
April 4, 2018
High-Density Lipoproteins: Effects on Vascular Function and Role in the Immune Response
Arash Haghikia, Ulf Landmesser
European Heart Journal
|
March 11, 2016
Emerging role of the gut microbiome for cardiovascular disease
Arash Haghikia, Ulf Landmesser
Trends in Cardiovascular Medicine
|
September 17, 2018
Editorial commentary: Peripartum cardiomyopathy: Long-term implications of treatment and management
Arash Haghikia, Denise Hilfiker-Kleiner
Cardiovascular Research
|
February 14, 2009
MiRNA-21: a key to controlling the cardiac fibroblast compartment?
Arash Haghikia, Denise Hilfiker-Kleiner
Heart Failure Reviews
|
April 22, 2010
STAT3 and cardiac remodeling
Arash Haghikia, Britta Stapel, Melanie Hoch, et al.
JAK-STAT
|
September 24, 2013
STAT3 regulation of and by microRNAs in development and disease
Arash Haghikia, Melanie Hoch, Britta Stapel, et al.
European Heart Journal
|
February 1, 2015
Peripartum cardiomyopathy: current management and future perspectives
Denise Hilfiker-Kleiner, Arash Haghikia, Justus Nonhoff, et al.
Frontiers in Cardiovascular Medicine
|
January 28, 2022
Immune Mechanisms of Plaque Instability
Teresa Gerhardt, Arash Haghikia, Philip Stapmanns, et al.
Page
of 12